Funding for this research was provided by:
This work was supported by Finch Therapeutics and the Arizona Board of Regents.
Text and Data Mining valid from 2019-04-09
Received: 3 December 2018
Accepted: 5 March 2019
First Online: 9 April 2019
: J.B.A., D.-W.K. and R.K.B. have pending/approved patents related to the use of FMT and/or probiotics for various conditions including autism (Application number: 14/403,425 (approved and active); 15/290,798 (pending)). J.B.A., R.K.B. and D.-W.K. have received research funding from Crestovo/Finch Therapeutics for FMT research. J.B.A., R.K.B. and J.G.C. have received consulting fees from Crestovo. The other authors declare no competing interests.